CSF2 and chronic myelogenous leukemia, BCR-ABL1 positive: This observation indicates a possible clinical utility of CD40-retargeted Ad-GM-CSF transduction for the induction of a mature T-cell stimulatory phenotype in CML-DC, which may be expected to be stable over protracted periods of time after adoptive transfer.